Exenatide
Aortic Valve Disorder
Rigshospitalet, Denmarkprotein_peptideN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Aortic Valve Disorder cohort.
Same molecule, other indications
Exenatide is also rated in:
metabolic dysfunction-associated steatotic liver diseaseDormant
BBB
Indicative · Phase 4
74 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →